NO20030128L
Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
Abstract
The invention claims the use and an antibody, Wherein The resisted-b7, Resists-cd23 or Resists-cd40l the antibody and B cell with the antibody, specifically Resists-cd19, Resists-cd20, Resists-cd22 or Resists-cd37 antibody, for treating B cell malignancies and antibody method for treating. With the method for treating a Resisting-b7 and Resisting-cd20 the alleviation of antibodies.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
1 claim: 1 independent, 0 dependent
- 1immunoregulatory antibody, especially an anti-B7, anti-CD23 or anti-CD40L antibody and a B cell-reducing antibody, especially anti-CD19, anti-CD20, anti CD22 or anti-CD37 antibody are provided. Preferably, the combination therapy will include anti-B7 and anti-CD20 antibody administration. immunregulerende antistoff, spesielt et anti-B7, anti-CD23 eller anti-CD40L antistoff og et Bcellereduserende antistoff, spesielt anti-CD19, anti-CD20, anti CD22 eller anti-CD37 antistoff er tilveiebrakt. Foretrukket vil kombinasjonsterapien omfatte anti-B7 og anti- CD20 antistoffadministrasjon.
9 paragraphs, as filed
(21) Application number (22) In day (24) Running day (41) Aim. avail.
2003.01.10
2001.05.16
2003.03.12 (86) Int entry date and application number (85) Date of transfer (30) Priority
2001.05.16, PCT / USOl / 15677 2003.01.10
2000.07.12, US, 217706 2001.01.31, US, 772938 (71) Seeking (72) Inventor (74) Proxy
Idea Pharmaceuticals Corp,
11011 Torreyana Road, San Diego, CA 92121-1104, US Nabil Hanna, Rancho Santa Fe, CA 92067, US Kandasamy Hariharan, San Diego, CA 92129, US Oslo Patent Office AS, 0306 Oslo (54) Denomination Treatment of B cell malignancy at use of combination of B cell reducing antibody and immune modulating antibody related applications (57) Summary
A combination antibody therapy for B cell malignancies using
183 members in 31 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 21770600 | United States of America | P | |
| 21770600 | United States of America | P | |
| 77293801 | United States of America | A | |
| 77293801 | United States of America | A | |
| 0115677 | United States of America | W | |
| 0115677 | United States of America | W | |
| 0115677 | – | – | – |
| 217706 | – | – | – |
| 772938 | – | – | – |
| US20000217706P | – | – | – |
| US20010772938 | – | – | – |
| WO2001US15677 | – | – | – |
Members183
| Document | Office | Kind | |
|---|---|---|---|
| UY24256A1 | Uruguay | A1 | |
| CA2223532A1 | Canada | A1 | |
| WO9640878A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6331296A | Australia | A | |
| ZA964547B | South Africa | B | |
| CO4480111A1 | Colombia | A1 | |
| AR001288A1 | Argentina | A1 | |
| NO975598D0 | Norway | D0 | |
| NO975598L | Norway | L | |
| EP0837927A1 | European Patent Office (EPO) | A1 | |
| CA2270922A1 | Canada | A1 | |
| WO9819706A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5100998A | Australia | A | |
| IL122370D0 | Israel | D0 | |
| CN1192779A | China | A | |
| YU35996A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| KR19990022650A | Republic of Korea | A | |
| NO992212D0 | Norway | D0 | |
| AU707023B2 | Australia | B2 | |
| BR9609035A | Brazil | A | |
| ID21676A | Indonesia | A | |
| NO992212L | Norway | L | |
| JPH11508764A | Japan | A | |
| NZ311904A | New Zealand | A | |
| HK1015413A1 | Hong Kong, China | A1 | |
| EP0837927A4 | European Patent Office (EPO) | A4 | |
| CN1244128A | China | A | |
| BR9713498A | Brazil | A | |
| EP1007090A1 | European Patent Office (EPO) | A1 | |
| IL122370A | Israel | A | |
| KR20000053137A | Republic of Korea | A | |
| US6113898A | United States of America | A | |
| HK1025741A1 | Hong Kong, China | A1 | |
| EP1007090A4 | European Patent Office (EPO) | A4 | |
| JP2001504693A | Japan | A | |
| CA2390412A1 | Canada | A1 | |
| WO0134194A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2249101A | Australia | A | |
| US2001018041A1 | United States of America | A1 | |
| US2001024648A1 | United States of America | A1 | |
| AU739058B2 | Australia | B2 | |
| WO0189567A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6474701A | Australia | A | |
| CA2415100A1 | Canada | A1 | |
| US2002006404A1 | United States of America | A1 | |
| WO0204021A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6461201A | Australia | A | |
| US2002028178A1 | United States of America | A1 | |
| NO20022174D0 | Norway | D0 | |
| NO20022174L | Norway | L | |
| CA2436180A1 | Canada | A1 | |
| CA2444661A1 | Canada | A1 | |
| WO02060484A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO02060485A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1229935A1 | European Patent Office (EPO) | A1 | |
| KR20020072277A | Republic of Korea | A | |
| MXPA02004599A | Mexico | A | |
| US2002159996A1 | United States of America | A1 | |
| IL149500D0 | Israel | D0 | |
| US2002187146A1 | United States of America | A1 | |
| NO20030128D0 | Norway | D0 | |
| WO0204021A9 | World Intellectual Property Organization (WIPO) | A9 | |
| NO20030128LThis record | Norway | L | |
| CN1407901A | China | A | |
| JP2003513937A | Japan | A | |
| KR20030031957A | Republic of Korea | A | |
| EP1305045A1 | European Patent Office (EPO) | A1 | |
| WO03039486A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002346373A1 | Australia | A1 | |
| US2003103971A1 | United States of America | A1 | |
| WO02060485A3 | World Intellectual Property Organization (WIPO) | A3 | |
| IL153764D0 | Israel | D0 | |
| NO20033417D0 | Norway | D0 | |
| NO20033418D0 | Norway | D0 | |
| US2003180290A1 | United States of America | A1 | |
| NO20033417L | Norway | L | |
| NO20033418L | Norway | L | |
| CN1446104A | China | A | |
| ZA200203631B | South Africa | B | |
| KR20030086992A | Republic of Korea | A | |
| US2003211107A1 | United States of America | A1 | |
| EP1370292A1 | European Patent Office (EPO) | A1 | |
| WO03039486A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1372724A2 | European Patent Office (EPO) | A2 | |
| RU2221590C2 | Russian Federation | C2 | |
| ZA200300293B | South Africa | B | |
| JP2004502742A | Japan | A | |
| IL157145D0 | Israel | D0 | |
| US6709654B1 | United States of America | B1 | |
| WO02060485A9 | World Intellectual Property Organization (WIPO) | A9 | |
| MXPA03000306A | Mexico | A | |
| CN1494433A | China | A | |
| EA200300846A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN1568198A | China | A | |
| JP2005503326A | Japan | A | |
| JP2005503999A | Japan | A | |
| ZA200305891B | South Africa | B | |
| CN1198646C | China | C | |
| US6893638B2 | United States of America | B2 | |
| US2005123540A1 | United States of America | A1 |
Showing 100 of 183
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Withdrawal, rejection or dismissal of laid open patent applicationFC2A | FC2A |
Numbers
- Publication, DOCDB
- 20030128
- Publication, EPODOC
- NO20030128L
- Application
- 128
- Application, DOCDB
- 20030128
- Application, EPODOC
- NO20030000128
Titles2
- Norwegian
- Behandling av B celle ondartethet ved anvendelse av kombinasjon av B cellereduserende antistoff og immun-modulerende antistoff beslektedeapplikasjoner
- English
- Treatment of B Cell Malignancy Using Combination of B Cell Reducing Antibody and Immune Modulatory Antibody Related Applications
Classification
- CPC, 11
- C07K16/2887
- A61K39/395
- A61K2039/505
- A61K2039/507
- A61P35/00
- C07K16/2827
- A61P35/02
- C07K16/2851
- A61P43/00
- C07K16/2875
- C07K2317/24
- IPC, 19
- A61K
- A61K31 166
- A61K31 196
- A61K45 00
- A61K31 282
- A61K31 475
- A61K31 519
- A61K31 573
- A61K31 675
- A61K31 704
- A61K31 7068
- A61K38 46
- A61K39 395
- A61K51 00
- A61P35 00
- A61P35 02
- A61P43 00
- C07K
- C07K16 28